Cold Chain and Vaccine Delivery — MCQs
Which vaccine is contraindicated in a 6-month-old infant whose sibling is on chemotherapy for leukemia?
Ideal temperature for DPT storage?
Assertion: VZV vaccine is live attenuated. Reason: It cannot be given to immunocompromised patients.
A child has received full rabies vaccination in December 2023 and now presented with an oozing wound on the great toe and the pet was also vaccinated. Next line of management is
Who is known as the father of microbiology?
Considering that dogs are the most common carriers of rabies and that the disease predominantly affects children in developing countries, what is the most effective and direct method to significantly reduce the incidence of rabies?
Which of the following is the most effective method to prevent malaria?
Which of the following statements about measles is incorrect?
6 year old son of pregnant woman is suffering from chicken pox. Which of the following is given to pregnant woman?
A young male came to the hospital with a clean-cut wound without any bleeding. The patient received a full course of tetanus vaccination 10 years ago. What is the best management for this patient?
Cold Chain and Vaccine Delivery Indian Medical PG Practice Questions and MCQs
Question 1: Which vaccine is contraindicated in a 6-month-old infant whose sibling is on chemotherapy for leukemia?
- A. Oral polio vaccine (Correct Answer)
- B. Hepatitis B
- C. Rotavirus vaccine
- D. DPT
Explanation: ***Oral polio vaccine*** - The **oral polio vaccine (OPV)** is a live attenuated vaccine containing weakened but live viruses. - It is **absolutely contraindicated** in individuals with immunocompromised household contacts (like a sibling on **chemotherapy**) due to the risk of **vaccine-associated paralytic poliomyelitis (VAPP)** from shedding of the live vaccine virus. - The shed virus can be transmitted to and cause disease in immunocompromised contacts. - This is the primary reason most countries have switched to **inactivated polio vaccine (IPV)**. *Hepatitis B* - The **Hepatitis B vaccine** is an inactivated (non-live) recombinant vaccine. - It poses no risk of transmitting live virus to an immunocompromised individual. - It is safe to administer to an infant with an immunocompromised household contact. *Rotavirus vaccine* - The **Rotavirus vaccine** is also a live attenuated vaccine, and there is a **relative contraindication** when household contacts are severely immunocompromised. - The vaccine virus can be shed in stool for several days after vaccination. - However, compared to OPV, the risk of serious disease transmission is considered much lower, and some guidelines allow its use with precautions (strict hand hygiene, avoiding diaper changes by immunocompromised contacts). - In the context of this question, **OPV has a stronger absolute contraindication** than rotavirus vaccine. *DPT* - The **DPT vaccine** (Diphtheria, Pertussis, Tetanus) is an **inactivated vaccine** containing toxoids and killed bacterial components. - It is safe to administer to an infant with an immunocompromised household contact as there is no risk of shedding live pathogens.
Question 2: Ideal temperature for DPT storage?
- A. Room temperature
- B. 4 to 8°C (Correct Answer)
- C. 0 to - 20°C
- D. None of the options
Explanation: ***4 to 8°C*** - The ideal temperature for DPT (diphtheria, pertussis, tetanus) vaccine storage is between **+2°C and +8°C** (or 35°F and 46°F), which is the standard refrigerator temperature range. - This temperature range is crucial for maintaining the **potency** and **efficacy** of the vaccine, preventing **degradation** due to excessive heat or cold. *Room temperature* - Storing DPT vaccines at **room temperature** (typically 20-25°C or 68-77°F) for extended periods can lead to a **loss of potency** as heat can degrade vaccine components. - While short-term excursions within this range might be permissible under specific conditions (e.g., during transport), it is not the ideal long-term storage solution. *0 to - 20°C* - DPT vaccines, particularly the **whole-cell pertussis (wP)** component, can be **damaged by freezing**. - Temperatures below 0°C can cause the **adjuvant** (usually aluminum salt) to separate, leading to a loss of efficacy and potential local reactions at the injection site. *None of the options* - This option is incorrect because **4 to 8°C** is indeed the established and recommended ideal storage temperature for DPT vaccines.
Question 3: Assertion: VZV vaccine is live attenuated. Reason: It cannot be given to immunocompromised patients.
- A. Both true, reason doesn't explain assertion
- B. Assertion true, reason false
- C. Assertion false, reason true
- D. Both true, reason explains assertion (Correct Answer)
Explanation: ***Both true, reason explains assertion*** - The **VZV (varicella-zoster virus) vaccine** is indeed a **live attenuated vaccine** containing weakened virus - the assertion is **TRUE** - It **cannot be given to immunocompromised patients** due to risk of vaccine-strain disease - the reason is **TRUE** - The reason **directly explains the assertion**: BECAUSE the vaccine is live attenuated, it poses infection risk and therefore cannot be used in immunocompromised individuals - The **causal relationship** is clear: live attenuated nature → contraindication in immunocompromised patients *Both true, reason doesn't explain assertion* - While both statements are factually true, this option would only be correct if the reason was unrelated to the assertion - However, the reason **directly explains WHY** the live attenuated nature is clinically significant - The contraindication is a **direct consequence** of the vaccine being live attenuated, so the reason does explain the assertion *Assertion true, reason false* - The assertion is true (VZV vaccine is live attenuated) - However, the reason is also **TRUE** - live attenuated vaccines are indeed contraindicated in immunocompromised patients due to risk of disseminated vaccine-strain infection - Since both statements are true, this option is incorrect *Assertion false, reason true* - The assertion is **TRUE**, not false - VZV vaccine (Varivax, Zostavax) is a **live attenuated vaccine** containing the Oka strain - This option incorrectly claims the assertion is false - Since the assertion is factually correct, this option cannot be right
Question 4: A child has received full rabies vaccination in December 2023 and now presented with an oozing wound on the great toe and the pet was also vaccinated. Next line of management is
- A. RIG + 5 doses of vaccine
- B. 5 doses of vaccines only
- C. No vaccine required
- D. 2 doses of Rabies vaccine (Correct Answer)
Explanation: ***2 doses of Rabies vaccine*** - For individuals who have received **previous full rabies vaccination** (either pre-exposure or post-exposure prophylaxis), a subsequent exposure requires only **two booster doses of vaccine on days 0 and 3**, regardless of wound category. - Even though this is a **Category III exposure** (oozing wound with break in skin), **no RIG is required** for previously immunized individuals as per WHO and APCRI guidelines. - The pre-existing immunity from the prior vaccination provides a **rapid anamnestic (memory) response**, eliminating the need for passive immunization or a full primary series. *RIG + 5 doses of vaccine* - This regimen is for individuals with **no prior vaccination history** and represents the full post-exposure prophylaxis for Category III exposures (transdermal bites, oozing wounds). - The child has been previously vaccinated, rendering this extensive protocol unnecessary and potentially harmful due to **immune complex formation** if RIG is given to an immune individual. *5 doses of vaccines only* - This approach is suitable for **previously unvaccinated individuals** with Category II exposure (nibbling, minor scratches without bleeding) where RIG may not be available. - However, in a previously vaccinated individual, the full 5-dose series is **excessive and not indicated** as immunity is already established. *No vaccine required* - Even with a previously vaccinated child and a vaccinated pet, there is still a **potential risk of exposure** to rabies, especially with a Category III wound (oozing wound). - Omitting vaccination entirely would be **negligent** and violates standard guidelines, as vaccine efficacy is not 100% and animal vaccination status can be uncertain or lapsed.
Question 5: Who is known as the father of microbiology?
- A. Robert Brown
- B. J.C. Bose
- C. Louis Pasteur
- D. Antonie van Leeuwenhoek (Correct Answer)
Explanation: ***Antonie van Leeuwenhoek*** - **Antonie van Leeuwenhoek** is widely recognized for his groundbreaking work in microscopy, which led to the discovery of microorganisms. - He was the first to observe and accurately describe bacteria, protozoa, and other microscopic life forms, which he called "animalcules," using single-lens microscopes of his own design. *Robert Brown* - **Robert Brown** was a Scottish botanist known for his important contributions to botany, including the discovery of the cell nucleus and the description of Brownian motion. - While significant in biology, his work primarily focused on plant structures and physics, not the direct study of microorganisms. *J.C. Bose* - **Jagadish Chandra Bose** was a polymath from British India, a physicist, biologist, botanist, and archaeologist. - He made pioneering contributions to the investigation of radio and microwave optics, made significant contributions to plant science, and was an early writer of science fiction, but his work was not in microbiology. *Louis Pasteur* - **Louis Pasteur** is famous for his discoveries concerning the principles of vaccination, microbial fermentation, and pasteurization. - While he is a pivotal figure in microbiology, often called the "father of modern microbiology" due to his foundational work on germ theory and disease, Van Leeuwenhoek predates him as the first to observe microorganisms.
Question 6: Considering that dogs are the most common carriers of rabies and that the disease predominantly affects children in developing countries, what is the most effective and direct method to significantly reduce the incidence of rabies?
- A. Conduct rabies testing for all dogs
- B. Control the stray dog population and vaccinate all dogs (Correct Answer)
- C. Enhance laboratory testing capabilities
- D. Improve healthcare worker training for disease surveillance
Explanation: ***Control the stray dog population and vaccinate all dogs*** - As dogs are the primary reservoirs of rabies, controlling their population, coupled with widespread **dog vaccination**, is the most direct and effective strategy to break the transmission cycle to humans. - This approach tackles the root cause of the disease in areas where dog-mediated transmission is endemic, leading to a significant reduction in human rabies cases. *Conduct rabies testing for all dogs* - While testing identifies infected animals, it is **resource-intensive** and impractical for large dog populations, especially in low-resource settings, and does not prevent future infections. - This strategy is reactive rather than **proactive** in preventing the spread of rabies. *Enhance laboratory testing capabilities* - Improving laboratory testing capabilities is crucial for **surveillance** and accurate diagnosis but does not directly prevent rabies transmission at the source. - It's a supportive measure that helps monitor disease burden but isn't the most effective **primary intervention** for incidence reduction. *Improve healthcare worker training for disease surveillance* - Training healthcare workers enhances case detection and reporting, which is vital for **epidemiological monitoring** and timely post-exposure prophylaxis (PEP). - However, it does not address the fundamental issue of rabies transmission from dogs to humans and is not a direct prevention method for reducing disease incidence.
Question 7: Which of the following is the most effective method to prevent malaria?
- A. Use of insecticide-treated nets (Correct Answer)
- B. Vaccination
- C. Antimalarial drugs
- D. Genetic modification of mosquitoes
Explanation: ***Use of insecticide-treated nets*** - **Insecticide-treated nets (ITNs)** provide a physical barrier against mosquitoes and kill mosquitoes that come into contact with the net. This dual action makes them highly effective, especially for vulnerable populations sleeping at night when **Anopheles mosquitoes** are most active. - Widespread distribution and proper use of ITNs have been shown to significantly reduce **malaria incidence** and mortality in endemic areas, making them a cornerstone of malaria prevention programs. *Vaccination* - The **RTS,S/AS01 (Mosquirix)** vaccine is the first and only vaccine recommended for broad use against malaria, primarily for children in regions with moderate to high transmission. - While a significant breakthrough, its efficacy is **moderate** (around 30-40% against severe malaria in children) and it requires multiple doses, making it less singularly effective than ITNs at a population level for immediate prevention. *Antimalarial drugs* - **Antimalarial drugs** are primarily used for treatment, but can also be used for **chemoprophylaxis** (preventive treatment) in travelers or specific vulnerable groups (e.g., pregnant women, infants). - While effective for individual prevention when taken consistently, mass drug administration for prevention faces challenges such as **drug resistance**, cost, adherence, and potential side effects, limiting its widespread and long-term population-level effectiveness compared to ITNs. *Genetic modification of mosquitoes* - **Genetic modification of mosquitoes** (e.g., using gene drive technology to introduce sterility or make mosquitoes resistant to carrying the parasite) is an emerging and promising research area. - This method is still in **experimental stages**, with significant ethical, ecological, and regulatory hurdles to overcome before it can be implemented as a widespread, effective prevention strategy.
Question 8: Which of the following statements about measles is incorrect?
- A. Secondary attack rate is 90%
- B. Maximum incidence in 6 months to 3 years age group
- C. Best age for immunization is 9-12 months
- D. Secondary attack rate is 30% (Correct Answer)
Explanation: ***Secondary attack rate is 30%*** - Measles is highly contagious, and its **secondary attack rate** is much higher than 30%, often reaching **90% or more** among susceptible household contacts. - A 30% secondary attack rate would be exceptionally low for a disease with measles's known **high transmissibility**. *Maximum incidence in 6 months to 3 years age group* - This statement is correct as **maternal antibodies wane** around 6 months, making infants susceptible, and young children in this age range are often actively exposed in community settings. - Peak incidence occurs in this age group, particularly in **unvaccinated or under-vaccinated populations**. *Best age for immunization is 9-12 months* - This is the **recommended age** for measles vaccination under India's **Universal Immunization Programme (UIP)**. - Immunizing at this age ensures that waning maternal antibodies do not interfere with vaccine efficacy while providing timely protection during the high-risk period. *Secondary attack rate is 90%* - This statement is correct. Measles is one of the **most contagious infectious diseases**, with a secondary attack rate among susceptible household contacts often **exceeding 90%**. - Its high transmissibility is due to its **airborne spread** and long communicable period.
Question 9: 6 year old son of pregnant woman is suffering from chicken pox. Which of the following is given to pregnant woman?
- A. Acyclovir + immunoglobulin
- B. Only immunoglobulin (Correct Answer)
- C. Vaccination
- D. Acyclovir
Explanation: ***Only immunoglobulin*** - Giving **immunoglobulin** to a pregnant woman exposed to **chickenpox** provides immediate passive immunity, which is crucial as she is at risk of infection from her child. - This is particularly important because chickenpox during pregnancy can lead to severe maternal disease and congenital varicella syndrome in the fetus. *Acyclovir + immunoglobulin* - **Acyclovir** is an antiviral that treats active varicella infection but is not typically given prophylactically in combination with immunoglobulin for exposure unless the woman is already immunocompromised or develops symptoms. - The primary goal for exposed pregnant women is preventing infection through passive immunity, not immediately treating a potential infection. *Vaccination* - **Varicella vaccine** is a live attenuated vaccine and is **contraindicated** during pregnancy due to the theoretical risk of fetal infection. - It is used for pre-conception immunity or post-exposure prophylaxis in non-pregnant individuals if given within a short window, but not for pregnant women. *Acyclovir* - **Acyclovir** is an antiviral medicine used to treat active chickenpox infections, not to prevent infection immediately after exposure. - It would be considered if the pregnant woman develops symptoms of chickenpox, but not as a primary prophylactic measure in this scenario.
Question 10: A young male came to the hospital with a clean-cut wound without any bleeding. The patient received a full course of tetanus vaccination 10 years ago. What is the best management for this patient?
- A. Single-dose tetanus toxoid (Correct Answer)
- B. Human tetanus immunoglobulin only
- C. Human tetanus immunoglobulin and a full course of vaccine
- D. No treatment required
Explanation: ***Single-dose tetanus toxoid*** - For a **clean-cut wound** in a patient who completed a **primary tetanus vaccination series** and received their last dose more than 5 years ago but less than 10 years ago, a **single booster dose** of tetanus toxoid is recommended. [1] - A booster ensures continued protection, as vaccine-induced immunity wanes over time, but the prior full course provides a robust anamnestic response with a single dose. *Human tetanus immunoglobulin and a full course of vaccine* - This regimen (tetanus immunoglobulin + vaccine) is typically reserved for patients with **unvaccinated status**, an **unknown vaccination history**, or a **severely contaminated wound** (e.g., rusty nail, soil contamination) who have not been fully vaccinated. - The patient had a **clean-cut wound** and completed a full course of vaccination 10 years ago, making immunoglobulin unnecessary and a full course of vaccine excessive. *Human tetanus immunoglobulin only* - Administering **tetanus immunoglobulin alone** is appropriate for immediate, passive immunity in situations where a patient is unvaccinated or has an unknown vaccination status and has a significant risk of tetanus from a contaminated wound. [2] - This patient has a clean wound and a history of full vaccination, so a booster is sufficient to stimulate active immunity. *No treatment required* - While the patient was fully vaccinated 10 years ago, the protection from tetanus vaccination can **wane over time**, especially after 5-10 years. - A **booster dose** is crucial to maintain adequate protection against tetanus, even for a clean wound, given the 10-year interval since the last dose.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free